This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
blockchain: Archive
Silk Road Medical (SILK) Stock Jumps 6.7%: Will It Continue to Soar?
by Zacks Equity Research
Silk Road Medical (SILK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
SILKNegative Net Change
blockchain momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Here is Why Growth Investors Should Buy Watsco (WSO) Now
by Zacks Equity Research
Watsco (WSO) is well positioned to outperform the market, as it exhibits above-average growth in financials.
WSONegative Net Change
blockchain earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Growth Investors Will Love Daqo (DQ)
by Zacks Equity Research
Daqo (DQ) is well positioned to outperform the market, as it exhibits above-average growth in financials.
DQPositive Net Change
blockchain earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Growth Investors Will Love United (UAL)
by Zacks Equity Research
United (UAL) is well positioned to outperform the market, as it exhibits above-average growth in financials.
UALNegative Net Change
blockchain earnings-growth growth-investing growth-investors growth-stocks
All You Need to Know About United (UAL) Rating Upgrade to Buy
by Zacks Equity Research
United (UAL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
UALNegative Net Change
blockchain earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Professional Holding (PFHD) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Professional Holding (PFHD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
blockchain earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes Greif (GEF) a New Buy Stock
by Zacks Equity Research
Greif (GEF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
GEFNegative Net Change
blockchain earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Codiak BioSciences, Inc. (CDAK) Rating Upgrade to Strong Buy
by Zacks Equity Research
Codiak BioSciences, Inc. (CDAK) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
blockchain earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About First Interstate BancSystem (FIBK) Rating Upgrade to Strong Buy
by Zacks Equity Research
First Interstate BancSystem (FIBK) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
FIBKNegative Net Change
blockchain earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Why Is AutoZone (AZO) Up 8.2% Since Last Earnings Report?
by Zacks Equity Research
AutoZone (AZO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
AZOPositive Net Change
blockchain cryptocurrency earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Vertiv Holdings Co. (VRT) Surges 5.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
Vertiv Holdings Co. (VRT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
VRTNegative Net Change GDYNNegative Net Change
blockchain momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Antero Resources (AR): Can Its 5.5% Jump Turn into More Strength?
by Zacks Equity Research
Antero Resources (AR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
ARNegative Net Change APAPositive Net Change
blockchain momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Does Albertsons Companies, Inc. (ACI) Have the Potential to Rally 29% as Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 28.5% in Albertsons Companies, Inc. (ACI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
ACIPositive Net Change
blockchain earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe MRC (MRC) Could Rally 64%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for MRC (MRC) points to a 64.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
MRCNegative Net Change
blockchain earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does Nabors (NBR) Have the Potential to Rally 31% as Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Nabors (NBR) points to a 30.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
NBRNegative Net Change
blockchain earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think SpringWorks Therapeutics (SWTX) Could Surge 212%: Read This Before Placing a Bet
by Zacks Equity Research
The mean of analysts' price targets for SpringWorks Therapeutics (SWTX) points to a 211.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
blockchain earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does Fortinet (FTNT) Have the Potential to Rally 37% as Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 37.4% in Fortinet (FTNT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
FTNTNegative Net Change
blockchain earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does Upstart Holdings, Inc. (UPST) Have the Potential to Rally 85% as Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at an 84.7% upside potential for Upstart Holdings, Inc. (UPST). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
UPSTPositive Net Change
blockchain earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does Navigator Holdings (NVGS) Have the Potential to Rally 33% as Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Navigator Holdings (NVGS) points to a 33.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
NVGSNegative Net Change
blockchain earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does BlueLinx (BXC) Have the Potential to Rally 60% as Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for BlueLinx (BXC) points to a 60% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
BXCPositive Net Change
blockchain earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe Driven Brands Holdings Inc. (DRVN) Could Rally 32%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 32.4% in Driven Brands Holdings Inc. (DRVN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
DRVNPositive Net Change
blockchain earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does NortonLifeLock (NLOK) Have the Potential to Rally 26% as Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 25.8% upside potential for NortonLifeLock (NLOK). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
blockchain earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Allison Transmission (ALSN) is a Top-Ranked Momentum Stock: Should You Buy?
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ALSNNegative Net Change
bitcoin blockchain momentum-investor momentum-stocks top-ranked
Kymera Therapeutics, Inc. (KYMR) Moves 9.6% Higher: Will This Strength Last?
by Zacks Equity Research
Kymera Therapeutics, Inc. (KYMR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
KYMRNegative Net Change DBVTNegative Net Change
blockchain momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Cross Country Healthcare, Inc. (CCRN) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Cross Country (CCRN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CCRNNegative Net Change
blockchain earnings-surprise price-change style-scores valuation